SUNACE
SUNACE
Certificate of analysis B26-0365 ACE-MGS 20 PH · magnesium stearate, pharmaceutical grade
July 2026 close · posted live Mon 3 Aug 2026

SUNACE

Australia · Leading through quality

Sun Ace Australia Pty Ltd
32-38 Remington Drive, Dandenong South VIC 3175
ABN 52 006 388 102 · +61 3 9702 9444 · sunace@sunace.com.au

Certificate of Analysis

COA-26-0365

Product

ACE-MGS20-PH

ACE-MGS 20 PH · magnesium stearate, pharmaceutical grade

Metallic stearates

Batch

B26-0365

Manufactured
19 Jul 2026
Best before
18 Jul 2028
Quantity made
1,953 kg
Works order
WO-2026-0365

Pharmacopoeial release

QP-PHARMA

Conforms to specification

Full monograph assay with retained sample. Certificate of analysis issued with every despatch.

Tested against

The published specification for ACE-MGS20-PH, released under QP-PHARMA.

Test Specification Result Off target Outcome
Yield 97.50 to 100.00 % 99.32 % — Pass
Assay 98.00 to 101.50 % 99.68 % — Pass
Heavy metals 0.0 to 10.0 ppm 2.5 ppm — Pass
Moisture 0.00 to 1.50 % 0.54 % — Pass
Metal content 6.20 to 7.40 % 6.66 % — Pass
Appearance vs standard 1 to 1 pass Conforms — Pass
Sieve residue 75 µm 0.00 to 0.50 % 0.03 % — Pass

Part batches supplied

Nothing off this run has been despatched. 127 kg is still on the floor.

3 pallets came off this run. Each carries its own label, so a claim can be answered against the pallets that were delivered rather than the whole batch.

Released by

Priya Raman

20 Jul 2026 at 10:50am

Made on RX-03 by Malcolm Rees

Despatched against

Still on the floor. 127 kg available.

  • The goods described were manufactured under a quality system certified to ISO 9001:2015.
  • A retained sample of this batch is held for the shelf life of the product.

Sun Ace Australia Pty Ltd, ABN 52 006 388 102. Results of testing carried out on the batch named above under quality plan QP-PHARMA. Results relate only to the batch tested. COA-GENERAL